Biotech News
Assembly Biosciences Announces Pricing of $175 Million in Equity Financings
investor.assemblybio.com2026-05-06 15:29 EST
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (“Assembly Bio”) (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced the pricing of an underwritten, registered offering (the